Etavopivat trials for Sickle cell disease

All Etavopivat trials · All Sickle cell disease trials

Phase breakdown

Recruiting trials studying Etavopivat for Sickle cell disease

• A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
  NCT05953584 · Phase: Phase 2 · Ages: 12 Years to 16 Years · Sex: All (male and female) · 9 locations
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 175 locations
• A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
  NCT06198712 · Phase: Phase 2 · Ages: 6 Months to 18 Years · Sex: All (male and female) · 18 locations

Common questions

How many trials study Etavopivat for Sickle cell disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.